1. A digest from evidence-based clinical practice guideline for IgA nephropathy 2020.
- Author
-
Suzuki, Hitoshi, Kikuchi, Masao, Koike, Kentaro, Komatsu, Hiroyuki, Matsuzaki, Keiichi, Takahashi, Kazuo, Ichikawa, Daisuke, Okabe, Masahiro, Obata, Yoko, Katafuchi, Ritsuko, Kihara, Masao, Kohatsu, Kaori, Sasaki, Takaya, Shimizu, Akihiro, Nakanishi, Koichi, Fukuda, Akihiro, Miyazaki, Yoichi, Muto, Masahiro, Yanagawa, Hiroyuki, and Suzuki, Yusuke
- Subjects
- *
HEMATURIA , *IGA glomerulonephritis , *PROGNOSIS , *DIAGNOSIS - Abstract
The 10-year renal survival rate in adult-onset IgAN is approximately 80-85%, while the 10-year renal survival rate in patients with childhood-onset IgAN is more than 90% (Fig. Etiology Although the etiology of IgAN remains unclear, mucosal immunity is involved in the etiology of IgAN due to its genetic background and disease progression due to upper respiratory tract infection. Treatment options Tonsillectomy Tonsillectomy is expected to improve urinary findings, including clinical remission, in patients with IgAN with CKD stage G1-G2 and proteinuria of up to 1 g/day. In 2020, the Research for Intractable Renal Diseases of the Ministry of Health, Labour and Welfare of Japan established the Committee of Guideline for IgA Nephropathy, which published (A Digest from Evidence-Based Clinical Practice Guideline for IgA Nephropathy 2020) on the website (jin-shogai.jp/policy/index.html). [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF